Oldest pages
Showing below up to 50 results in range #101 to #150.
- 26. Causes, types and pathomechanisms of shock. Disseminated intravascular coagulation (DIC) (10:32, 6 May 2022)
- 27. Clinicopathological classification of hypertension and complications (10:35, 6 May 2022)
- 28. Vascular and cellular mechanisms and mediators of acute inflammation (10:46, 6 May 2022)
- 29. Clinicopathological classification of acute inflammation. Organ examples. (10:51, 6 May 2022)
- 30. Definition, causes, cellular and humoral mechanisms of chronic inflammation (20:36, 7 May 2022)
- 33. Type I. and type II. hypersensitivity reactions, mechanisms and related disorders (20:50, 7 May 2022)
- 34. Type III. and type IV. hypersensitivity reactions, related disorders (20:53, 7 May 2022)
- 35. Pathogenesis of autoimmune disorders (20:55, 7 May 2022)
- 36. Systemic lupus erythematodes (SLE) (20:57, 7 May 2022)
- 37. AIDS. Transplantation immunity (20:59, 7 May 2022)
- 38. Neoplasia, nomenclature, definitions. Terminology (nomenclature) of neoplasms (21:04, 7 May 2022)
- 39. Definition of metaplasia, dysplasia and their relation to neoplasia. Organ examples. Hamartoma and choristoma (21:08, 7 May 2022)
- 40. General characteristics of benign and malignant tumours. Anaplasia. Rate of tumour cell growth. Local spread and metastasis of malignant neoplasms. Types of metastases. (21:11, 7 May 2022)
- 41. Epidemiology of cancers. Incidence and mortality. Changes in death rates of cancers in the last decades (21:13, 7 May 2022)
- 42. Oncogenes, protooncogenes, oncoproteins. Growth factor and growth factor receptor oncogenes (RET, KIT, PDGFR). Overexpression of normal growth factor receptors (ERBB1, ERBB2). Organ examples. (21:17, 7 May 2022)
- 43. Oncogenes and oncoproteins in signal transduction: RAS and RAS-signal proteins. Examples for oncogene with non-receptor tyrosine kinase function. (21:19, 7 May 2022)
- 44. The myc oncogene. Types and their changes and role in tumours (c-myc, n-myc). Cell cycle regulators: p16 gene (21:21, 7 May 2022)
- 45. Tumour suppressor genes I. RB and p53. Their role in tumorigenesis. Organ examples (21:23, 7 May 2022)
- 46. Tumour suppressor genes II. NF1, NF2, VHL, WT-1 and WT-2. Related syndromes (21:24, 7 May 2022)
- 47. Chemical and radiation cancerogenesis. The multistep carcinogenesis of colorectal adenocarcinoma (21:26, 7 May 2022)
- 48. Microbial carcinogenesis. RNA and DNA viruses. Helicobacter pylori (21:28, 7 May 2022)
- 50. Grading and staging. Laboratory diagnosis of cancer (21:31, 7 May 2022)
- 6. Acute pancreatitis – adiponecrosis (08:42, 9 May 2022)
- 3. Anaemic infarct of the spleen and splenomegaly (14:01, 22 May 2022)
- 6. Gangraena sicca of the toes (14:06, 22 May 2022)
- 7. Cerebral abscess (14:07, 22 May 2022)
- 8. Acute pancreatitis with adiponecrosis (14:10, 22 May 2022)
- 9. Steatosis hepatis (14:11, 22 May 2022)
- 12. Systemic amyloidosis (14:24, 22 May 2022)
- 14. Table of frequent bilestones (14:30, 22 May 2022)
- 16. Cerebral atrophy (14:32, 22 May 2022)
- 17. Concentric hypertrophy of the left ventricle of the heart (14:36, 22 May 2022)
- 20. Prostatic hyperplasia (14:40, 22 May 2022)
- 21. Cerebral apoplexy (14:42, 22 May 2022)
- 23. Abdominal aortic aneurysm, parietal thrombosis (14:43, 22 May 2022)
- 24. Left atrial ball thrombus (14:46, 22 May 2022)
- 26. Pseudomembranous colitis (14:48, 22 May 2022)
- 27. Lobar pneumonia (14:49, 22 May 2022)
- 28. Bronchopneumonia (14:51, 22 May 2022)
- 32. Sarcoidosis – BHL (14:57, 22 May 2022)
- 33. Miliary tuberculosis of the lungs (14:57, 22 May 2022)
- 35. Fibroadenoma of breast (14:59, 22 May 2022)
- 37. Leiomyoma of uterus (15:01, 22 May 2022)
- 39. Rectal polyp (15:03, 22 May 2022)
- 41. Pulmonary metastases (15:05, 22 May 2022)
- 42. Lymphangitis carcinomatosa (15:06, 22 May 2022)
- 45. Endocarditis chronica – mitral stenosis (15:10, 22 May 2022)
- 47. Congestive cardiomyopathy (15:13, 22 May 2022)
- 50. Ventricular septal defect (Roger’s disease) (15:19, 22 May 2022)
- 51. Ductus Botalli persistens (15:21, 22 May 2022)